-
Mashup Score: 3Health emergencies: prepared without leaving cancer pts behind - 1 month(s) ago
ESMO is advocating for secondary and tertiary care levels to be included into international agreements and WHO’s documents to respond to pandemics
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9ESMO Daily Reporter - 1 month(s) ago
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5ESMO Daily Reporter - 2 month(s) ago
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Source: dailyreporter.esmo.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5ESMO Daily Reporter - 2 month(s) ago
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Source: dailyreporter.esmo.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5ESMO Daily Reporter - 2 month(s) ago
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Source: dailyreporter.esmo.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35Are ADCs in lung cancer living up to expectations? - 2 month(s) ago
High rates of adverse events in the experimental setting seem to limit the potential of antibody–drug conjugates for patients with NSCLC
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Incorporating ctDNA into clinical trial design - 2 month(s) ago
ctDNA offers immense possibilities for improving the management of early-stage lung cancer
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16How can proteomics aid the study of lung cancer in never smokers? - 2 month(s) ago
Personalised proteogenomics has the power to transform the identification, staging and management of NSCLC in never smokers
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 31Post-progression data confirm benefits of novel combos NSCLC - 2 month(s) ago
Analyses of FLAURA2, MARIPOSA, MARIPOSA-2 trials provide further guidance on treatments for advanced lung cancer, questions remain about sequencing
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20Subcutaneous administration become as standard for immunotherapy? - 2 month(s) ago
Studies add further evidence of the advantages of this route for delivering immune checkpoint inhibitors for patients and healthcare sustainability
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
#WorldHealthDay is approaching. ESMO reiterates its commitment to ensuring that all people have access to the care they need, regardless of the complexity of their disease. 👉https://t.co/R1AEotvfQ4 https://t.co/55JuDgAnjt